STING1 and neoplasm: There was no significant difference in the tumor burden between vehicle or 6TdG treated Sting KO 984 tumors (Fig. 5g), suggesting that in this SCLC model system the therapeutic effects of 6TdG are dependent on tumor cell STING expression.